AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 526.00 Change Price %
High 531.50 1 Day -0.65 -0.12
Low 515.80 1 Week -75.50 -12.56
Close 525.55 1 Month -97.25 -15.61
Volume 5009819 1 Year -216.85 -29.21
52 Week High 895.00
52 Week Low 515.80
AUROPHARMA Important Levels
Resistance 2 540.10
Resistance 1 534.11
Pivot 524.28
Support 1 516.99
Support 2 511.00
NSE INDIA Most Active Stocks
SINTEX 25.85 -75.17%
JPASSOCIAT 11.50 23.66%
SUZLON 19.35 2.65%
VEDL 232.60 3.89%
ICICIBANK 317.70 3.59%
SOUTHBANK 25.70 1.78%
DISHTV 81.55 -10.53%
GMRINFRA 15.20 4.47%
IDFC 57.60 1.23%
RCOM 25.95 0.19%
More..
NSE INDIA Top Gainers Stocks
LCCINFOTEC 0.25 25.00%
JPASSOCIAT 11.50 23.66%
ELECTHERM 285.30 20.00%
TECHNOFAB 219.95 19.99%
GLOBALVECT 123.95 19.99%
MVL 0.65 18.18%
MVL 0.65 18.18%
KMSUGAR 22.50 17.80%
VIVIMEDLAB 114.70 17.04%
WEIZFOREX 603.95 16.81%
More..
NSE INDIA Top Losers Stocks
ADVENZYMES 402.25 -78.33%
SINTEX 25.85 -75.17%
HINDCOMPOS 689.25 -64.39%
RAJRAYON 0.15 -25.00%
SHREYAS 281.05 -19.46%
NAGREEKEXP 32.30 -11.26%
DISHTV 81.55 -10.53%
VIDEOIND 53.15 -9.99%
MBLINFRA 29.90 -8.00%
FLEXITUFF 132.55 -7.95%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 5
As on 25th May 2017 AUROPHARMA Share Price closed @ 525.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 720.25 & Strong Sell for SHORT-TERM with Stoploss of 638.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for May
1st Target up-side 651.93
2nd Target up-side 683.6
3rd Target up-side 715.27
1st Target down-side 561.57
2nd Target down-side 529.9
3rd Target down-side 498.23
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 21.91 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 605.73
10 Day Avg Volume Traded 93.55 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.